Welcome to our dedicated page for AvePoint SEC filings (Ticker: AVPT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
AvePoint, Inc. filings document the company’s financial results, governance matters, capital structure and public-company securities activity. Form 8-K reports furnish quarterly and annual operating results, including SaaS revenue, total revenue, annual recurring revenue and related financial-condition disclosures tied to the company’s cloud data protection business.
Proxy materials and annual meeting reports cover director elections, executive compensation votes, auditor ratification and board governance. Other filings address common stock offering activity under shelf registration materials, the company’s secondary listing context for common stock, and the removal of AvePoint warrants from Nasdaq listing and registration.
AvePoint, Inc. is registering the resale of 13,290,360 shares of common stock by selling securityholders in connection with a secondary listing on the Singapore Exchange (SGX-ST). The company will not receive any proceeds from these sales; the selling holders are expected to receive approximately US$196.1M before expenses. The public offering price is S$19.50 per share, with underwriting discounts of S$0.585 per share. An over-allotment option allows underwriters to purchase up to 1,993,550 additional shares from KEM Phoenix, solely to cover over-allotments. Settlement will occur exclusively through Singapore’s CDP system, and the SGX-ST listing will trade in Singapore dollars under the symbol AVP. For 2024, AvePoint reported total revenue of $330.5M and turned an operating profit of $7.2M, with ARR reaching $327.0M and free cash flow of $85.9M.
AvePoint, Inc. is registering 13,290,360 shares of common stock for resale by selling securityholders in a secondary offering tied to a planned secondary listing on the Singapore Exchange (SGX-ST).
The company will not receive proceeds from these sales, including up to 1,993,550 additional shares subject to an over-allotment option granted by Phoenix, LLC. AvePoint’s common stock already trades on Nasdaq under “AVPT” and is expected to trade on SGX-ST under “AVP,” with a 30‑day Non‑Fungibility Period limiting transfers from SGX-ST back to Nasdaq after listing. As of June 30, 2025, 211,138,994 shares were outstanding, with 211,926,808 shares expected outstanding after the offering.
Operationally, AvePoint reported 2024 revenue of $330,482,000, up from $271,825,000 in 2023, and turned to net income of $6,459,000 for the six months ended June 30, 2025 versus a net loss in the prior‑year period. Total ARR reached $367.6 million as of June 30, 2025, with FX‑adjusted dollar‑based net retention of 112% and free cash flow of $18,286,000 for the first half of 2025, highlighting growing recurring SaaS revenues and improving profitability.
Caci James, Chief Financial Officer of AvePoint, Inc. (AVPT), reported a Section 16 Form 4 disclosing a non-discretionary share disposition on 09/05/2025. The filing shows 3,957 shares of common stock were disposed of at a price of $16.27 per share as an exempt transaction where shares were withheld to satisfy tax withholding related to the net settlement of restricted stock units (RSUs). After the withholding, the reporting person beneficially owns 667,833 shares, which includes both non-RSU common stock and aggregate vested and unvested RSUs subject to previously reported vesting schedules. The Form 4 was signed by an attorney-in-fact on 09/09/2025.
AvePoint insider transaction summary: The company reported that Brian Michael Brown, Chief Legal Officer and a director, reduced his direct holdings by 2,835 shares of common stock through an exempt withholding to satisfy tax obligations related to the net settlement of vested restricted stock units (RSUs). The transaction price per share was reported as $16.27. After the withholding, Mr. Brown is recorded as beneficially owning 1,145,298 shares, which includes both non-RSU common stock and aggregate vested and unvested RSUs previously disclosed. The filing notes the share withholding was not a discretionary sale by the reporting person but an administrative action to satisfy tax withholding and remittance obligations.
Brian Michael Brown, Chief Legal Officer and a director of AvePoint, Inc. (AVPT), reported a routine disposition of 7,310 shares of the issuer's common stock on 08/29/2025 at a price of $16.36 per share. The Form 4 states this was an exempt transaction: shares were withheld by the company to satisfy tax withholding obligations arising from the vesting of restricted stock units granted under the 2021 Equity Incentive Plan rather than a discretionary open-market sale. After the transaction, Brown beneficially owned 1,148,133 shares, which include both non-RSU common stock and vested and unvested RSUs reported in prior Form 4 filings. The Form 4 is signed and dated 09/02/2025.
AvePoint, Inc. director and 10% owner Gong Xunkai reported a non-derivative disposition of 10,572 common shares on 08/29/2025 at a price of $16.36 per share. The filing states this was an exempt transaction where the company withheld shares to satisfy tax withholding obligations related to the net settlement of restricted stock units (RSUs). After the withholding, the reporting person beneficially owned 757,155 shares (including vested and unvested RSUs previously disclosed). The disposition is described as administrative and not a discretionary sale by the reporting person.
AvePoint insider transaction by CEO/director and 10% owner Jiang Tianyi shows a net settlement of restricted stock units on 08/29/2025. The filing reports 7,654 shares disposed at a price of $16.36 withheld to satisfy tax obligations arising from vesting/exercise under the 2021 Equity Incentive Plan. After this withholding, the reporting person beneficially owned 559,254 shares, which includes vested and unvested RSUs previously reported on Form 4 filings in 2021–2025. The transaction is reported as an exempt in-kind withholding under Rule 16b-3 and appears to be an administrative, non-discretionary net settlement.
AvePoint, Inc. insider sale notice: The filing reports a proposed sale of 35,000 shares of common stock by a person associated with AVPT through Rockefeller Financial with an aggregate market value of $540,484.90, with an approximate sale date of 08/25/2025. The shares were acquired as a restricted stock grant on 07/07/2022 and were granted as compensation. The issuer has 211,926,808 shares outstanding. The filer previously sold three blocks of 35,000 shares on 05/23/2025, 06/23/2025 and 07/23/2025 with gross proceeds of $635,482.33, $638,057.00 and $654,941.73 respectively. The signer represents no undisclosed material adverse information and notes Rule 144 sale reporting requirements.
AvePoint, Inc. (AVPT) insider transaction summary: Chief Legal Officer and director Brian Michael Brown reported a sale of 35,000 shares of common stock on 08/25/2025 at a price of $15.47 per share. The filing states the sale was effected under a Rule 10b5-1 trading plan adopted December 18, 2024.
Following the reported sale, Mr. Brown beneficially owns 1,155,443 shares, a total that the form clarifies includes both non-RSU common stock and aggregate vested and unvested RSUs subject to previously disclosed vesting schedules. The Form 4 is signed and dated 08/27/2025.